Saturn V Capital Management LP
Q2 2025 13F Holdings
- Locationaustin, TX
- Num holdings24 
- Value ($000)$246,761 
- Date Filed08/13/2025
- Form type13F-HR
- CIK0001964437
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter   
| Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type | 
|---|---|---|---|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | $21.96 M | 9 % | 206,952 | ||
| IRON DISC MEDICINE INC | COM | 254604101 | $20.98 M | 9 % | 396,115 | ||
| AMLX AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | $20.90 M | 9 % | 3,260,570 | ||
| PCVX VAXCYTE INC | COM | 92243G108 | $17.69 M | 7 % | 544,221 | ||
| COGT COGENT BIOSCIENCES INC | COM | 19240Q201 | $16.50 M | 7 % | 2,297,524 | ||
| CELC CELCUITY INC | COM | 15102K100 | $15.83 M | 6 % | 1,185,520 | ||
| CGON CG ONCOLOGY INC | COM | 156944100 | $15.25 M | 6 % | 586,647 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | $14.66 M | 6 % | 468,364 | ||
| DYN DYNE THERAPEUTICS INC | COM | 26818M108 | $13.86 M | 6 % | 1,455,429 | ||
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | $13.73 M | 6 % | 290,784 | 
Rows Per Page
10
- 10
- 50
- 100